MIP as Drug Delivery Systems of Anticancer Agents
Author:
Feng Jing,Liu Zhaosheng
Publisher
Springer Singapore
Reference59 articles.
1. Hema S, Thambiraj S, Shankaran DR (2018) Nanoformulations for targeted drug delivery to prostate cancer: an overview. JNN 18:5171–5191
2. Vivek R, Thangam R, Nipunbabu V, Ponraj T, Kannan S (2014) Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a “smart” drug delivery system to breast cancer cell therapy. Int J Biol Macromol 65:289–297
3. Maeda H, Tominaga K, Iwanaga K, Nagao F, Habu M, Tsujisawa T, Seta Y, Toyoshima K, Fukuda J, Nishihara T (2009) Targeted drug delivery system for oral cancer therapy using sonoporation. J Oral Pathol Med 38:572–579
4. Masood F (2016) Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C Mater Biol Appl 60:569–578
5. Goldstein D, Nassar T, Lambert G, Kadouche J, Benita S (2005) The design and evaluation of a novel targeted drug delivery system using cationic emulsion–antibody conjugates. J Control Release 108:418–432